CLINICAL ROLE -
Direct and Indirect Cost Burden of Chronic Hepatitis C
An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Read More
Integrated Multi-Omic Data: Powering Precision Medicine
Researchers Use CRISPER Screens to Identify Factors Influencing Trastuzumab Emtansine Sensitivity, Resistance
FDA Grants Accelerated Approval to Atrasentan for Proteinuria Reduction in Primary IgA Nephropathy
Nivolumab May Restore T-Cell Fitness Following CAR T-Cell Therapy in Patients With Multiple Myeloma